Clinical Trials Browser

Esophageal Squamous Cell Carcinoma

Colonic Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, DNA Repair-Deficiency Disorders

Colorectal Neoplasms

Urinary Bladder Neoplasms

Lung Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Muscle-invasive Bladder Cancer

Carcinoma, Transitional Cell

Carcinoma, Hepatocellular

Small Cell Lung Carcinoma

Breast Neoplasms

Small Cell Lung Carcinoma

Carcinoma, Non-Small-Cell Lung

Carcinoma, Hepatocellular

Venous Thrombosis

Carcinoma, Hepatocellular

Prostatic Neoplasms

Carcinoma, Carcinoma, Hepatocellular, Neoplasms

Non Small Cell Lung Cancer Metastatic

Colorectal Neoplasms

Extensive Stage Small Cell Lung Cancer

Small Cell Lung Carcinoma

Breast Neoplasms

Carcinoma, Uterine Cervical Neoplasms

Urinary Bladder Neoplasms

Triple Negative Breast Neoplasms

Invasive Breast Cancer

Clinical Trials

SKYSCRAPER-07

Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study

A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)

Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer

Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)

Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer

An Extension Study in Participants Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella C)

A Study of Atezolizumab in High PD-L1 Expression, Chemotherapy-Naïve Patients With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer

IMvigor011

IMAGINE

IMbrave050

IMforte

Astefania

SKYSCRAPER-02C

Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]

A Study of TACE Combined With Atezolizumab Plus Bevacizumab or TACE Alone in Patients With Untreated Heaptocellular Carcionma

IMbrella B

TALENTOP

SKYSCRAPER-14

CONTACT-02

COSMIC-312

ELDERLY

STELLAR-303

To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC

KEYVIBE-008

AMBITION

BEATcc

ALBAN

Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo

APTneo